AbbVie Inc (ABBV)
201.31
-7.86
(-3.76%)
USD |
NYSE |
Mar 25, 16:00
201.41
+0.10
(+0.05%)
After-Hours: 20:00
AbbVie Enterprise Value: 430.89B for March 24, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Amgen Inc | 217.01B |
| Gilead Sciences Inc | 147.99B |
| Johnson & Johnson | 405.62B |
| Eli Lilly and Co | 807.13B |
| Merck & Co Inc | 256.66B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -22.00M |
| Revenue (Quarterly) | 15.10B |
| Total Expenses (Quarterly) | 15.02B |
| EPS Diluted (Quarterly) | -0.02 |
| Gross Profit Margin (Quarterly) | 70.89% |
| Profit Margin (Quarterly) | -0.15% |
| Earnings Yield | 1.19% |
| Operating Earnings Yield | 3.33% |
| Normalized Earnings Yield | 1.766 |